ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1195

Identification of Follicular Helper T Cells As a Novel Cell Population Potentially Involved in the Pathogenesis of Rheumatoid Arthritis

Sharon Ing1, Anika Alarakhia1, Elvira Lindwall1, Austin Fraser1, Jerald M. Zakem1, William E. Davis1, Tamika A. Webb-Detiege1, Robert Quinet1 and Xin Zhang2, 1Rheumatology, Ochsner Medical Center, New Orleans, LA, 2Institute of Translational Research, Ochsner Medical Center, New Orleans, LA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: autoantibodies, interleukins (IL) and rheumatoid arthritis (RA), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumamtoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovium, causing progressive joint destruction and reduction in quality of life for patients. The treatment of RA is largely based on management of the clinical consequences and manifestation of joint inflammation, which is likely to be remote from the fundamental pathophysiologic defects. Identification of cellular subsets or biomarkers that differentiate distinct clinic features according to the pathophysiologic defects is a necessary first step toward making a more accurate prognosis and better therapeutic decisions. Here, we identify a novel T cell subset, follicular helper T cells (Tfh) in RA patients and examine the hypothesis that Tfh cells may participate in the pathogenesis in RA by fostering an environment for  self-reactive B cells, resulting in autoantibody production.

Methods:

Peripheral blood was collected from 20 RA patients meeting 2010 ACR/EULAR RA classification criteria and age/gender matched healthy donors. Synovial fluid specimens from actively inflamed joints of RA patients were also collected. Clinical disease activity was quantified using the Disease Activity Score in 28 joints (DAS-28). RA patients were divided into remission, mild/moderate, and severe groups based on their DAS-28 score. Serum laboratory measurements including Rheumatoid factor, anti-cyclic citrullinated peptide, Erythrocyte sedimentation rate and C Reactive Protein levels were obtained. Tonsil specimens were obtained from discarded surgical tissue of non-RA patients and used as positive controls. Surface phenotype (CXCR5, CD57, ICOS, PD-1, BTLA) and intracellular cytokine (IL-21) production were used to identify Tfh cells in RA peripheral blood, RA synovial fluid, and normal tonsil by flow cytometry and/or immunohistochemical staining.  Surface phenotype CD20 and CD38 were used to identify plasmablasts. IgG production was measured by ELISA from the co-culture of autologous B cells with their respective tonsillar Tfh cells, or RA peripheral blood Tfh and non-Tfh cells.

Results:

A novel T cell subset with Tfh cell surface molecule and signature cytokine was identified in both of the peripheral blood and the synovial fluid from RA patients.  The percentage of these Tfh-like cells was expanded in the peripheral blood and synovial fluid of active RA patients (DAS-28 > 2.6) (P<0.05), compared to healthy donors and RA patients in remission (DAS-28 <2.6). The percentage of Tfh-like cells in CD4+ T cells of the peripheral blood of RA patients correlated with the percentage of plasmablasts in the total lymphocyte population, and also with the level of pathogenic auto-antibody (anti-CCP) and DAS-28. IgG levels were significantly increased in co-culture of Tfh-like cells and peripheral blood B cells of RA patients, but not in co-culture of non-Tfh-like cells and RA peripheral B cells.

Conclusion:

Identification of an expanded population of Tfh-like cells in RA patients provides evidence that a distinctive germinal center pathway maybe involved in RA pathogenesis resulting in  autoimmunity. Targeting RA-Tfh-like cells may provide more precise treatment strategies.


Disclosure:

S. Ing,
None;

A. Alarakhia,
None;

E. Lindwall,
None;

A. Fraser,
None;

J. M. Zakem,
None;

W. E. Davis,
None;

T. A. Webb-Detiege,
None;

R. Quinet,
None;

X. Zhang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-follicular-helper-t-cells-as-a-novel-cell-population-potentially-involved-in-the-pathogenesis-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology